Category Archives: Cellular Health

T Cells and Longevity: A Closer Look at the Immune Signature of Healthy Aging

T Cells and Longevity: A Closer Look at the Immune Signature of Healthy Aging

What does healthy aging look like? Emerging science suggests that T cells, other immune-cell populations, and blood-protein signatures may offer a snapshot. New research into age-related changes in T cells and the possibility that particular immune-cell populations, along with blood-protein signatures, could help identify patterns associated with longevity, is bringing scientists closer to understanding what distinguishes healthy aging from disease-associated aging on a cellular level. These findings may also help explain why some people remain healthier longer while others are more prone to age-related conditions.

Continue reading →

Beyond Senolytics - The Emerging Era of Precision Senescence Medicine

Beyond Senolytics: The Emerging Era of Precision Senescence Medicine

Cellular Senescence and Senotherapeutics

Cellular senescence was once considered “the end” – a point where cultured somatic cells simply stopped proliferating. The recent recognition of senescence as a central mechanism underlying aging and the development of age-associated disorders has given rise to senotherapeutics, a class of therapies dedicated to targeting cellular senescence and either eliminating senescent cells or modifying their senescence-associated secretory phenotype (SASP), the pro-inflammatory factors they secrete. Because the accumulation of senescent cells contributes to tissue dysfunction, chronic inflammation, and age-related diseases, emerging anti-aging and regenerative medicine strategies are evolving into precision senescence medicine and taking aim at cellular senescence to enhance human healthspan.

Continue reading →

Versatile Extracellular Vesicles and the Role They Play in Longevity

Versatile Extracellular Vesicles and the Role They Play in Longevity

From diagnostics to drug delivery to regenerative medicine, extracellular vesicles (EVs) are the messengers of the moment, offering a promising glimpse of future applications to the biologists who study them and the longevity experts interested in their powerful signaling properties. No EV-based therapeutic product has yet been formally approved for marketing, but clinical evidence is building around possible applications for EVs in the future – and their implications for longevity and regenerative medicine.

Continue reading →